Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction-Reference-Cited by-同舟云学术

Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction

Published:2017-05-30 Issue:22 Volume:135 Page:2085-2087
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Messerli Franz H.¹,Bangalore Sripal¹

Affiliation:

1. From Department of Cardiology and Clinical Research, University Hospital, Bern, Switzerland (F.H.M.); Jagiellonian University, Krakow, Poland (F.H.M.); Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NY (F.H.M.); and Leon H. Charney Division of Cardiology, New York University School of Medicine (S.B.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025950

Reference5 articles.

1. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2. Angiotensin receptor blockers and myocardial infarction

3. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

4. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials

5. Fraudulent data: an apology and the fate of angiotensin receptor blockers

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European guidelines for the treatment of arterial hypertension 2023: new trends;Meditsinskiy sovet = Medical Council;2024-05-09

2. Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study;Pharmaceuticals;2023-09-14

3. Prognosis and personalizedin-silicoprediction of treatment efficacy in cardiovascular and chronic kidney disease: a proof-of-concept study;2023-08-06

4. Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction;PLOS ONE;2023-03-09

5. Association between renin–angiotensin–aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort;Clinical Research in Cardiology;2023-03-03